Xylem Raised EPS Outlook Spurs Buy Call, but Backlog and Mix Concerns Linger

What happened

Xylem shares have struggled with sentiment after a Q1 revenue miss, but a Q2 beat and raised full-year EPS guidance renewed bullish calls on secular drivers like AI data centers and digital water. The Seeking Alpha article highlights a 15% discount to fair value and 20% upside potential, but the master report notes Q1 organic revenue slipped 0.4% and backlog fell 7.5% YoY. While the EPS raise is encouraging, it’s unclear if it stems from volume recovery or one-time items, as margins remain squeezed by inflation and strategic investments. Xylem’s data-center narrative has yet to translate into meaningful organic growth, with Applied Water still near flat. The rebound in sentiment needs proof from order and backlog trends in coming quarters to sustain a re-rating.

Implication

The raised EPS outlook slightly de-risks the margin thesis but doesn’t yet resolve the Q1 organic decline or backlog slide. Xylem’s 21x forward P/E already prices in a recovery that hinges on Applied Water volume and backlog stabilization. Next quarter must show Applied Water organic revenue turning positive and mix headwinds shrinking, or the stock risks slipping toward our $98 attractive entry. Confirmation of data-center bookings converting to revenue with better margins could justify a move to $128. For now, we stay on the sidelines until the narrative shifts from promise to proof in the P&L.

Thesis delta

The Seeking Alpha article highlights a Q2 EPS raise and data-center optimism, slightly improving the near-term risk/reward. However, our core concerns—declining backlog, soft organic growth, and margin mix pressure—remain until Q3 data confirms a turnaround. The WAIT rating is unchanged; we need Applied Water organic growth and backlog stabilization before upgrading.